Paving the way to a bioresorbable technology: Development of the absorb BRS program.


Bioresorbable scaffolds (BRS) combine attributes of the preceding generations of percutaneous coronary intervention (PCI) devices with new technologies to result in a novel therapy promoted as being the fourth generation of PCI. By providing mechanical support and drug elution to suppress restenosis, BRS initially function similarly to drug eluting stents… (More)
DOI: 10.1002/ccd.26811